Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer: A Systematic Review with Meta-Analysis

BACKGROUND: This study aims to comprehensively summarize the currently available evidences on the efficacy and safety of gemcitabine plus erlotinib for treating advanced pancreatic cancer. METHODOLOGY/PRINCIPAL FINDINGS: PubMed, EMBASE, The Cochrane Library and abstracts of recent major conferences...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Zu-Yao, Yuan, Jin-Qiu, Di, Meng-Yang, Zheng, Da-Yong, Chen, Jin-Zhang, Ding, Hong, Wu, Xin-Yin, Huang, Ya-Fang, Mao, Chen, Tang, Jin-Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589410/
https://www.ncbi.nlm.nih.gov/pubmed/23472089
http://dx.doi.org/10.1371/journal.pone.0057528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3589410/
https://www.ncbi.nlm.nih.gov/pubmed/23472089
http://dx.doi.org/10.1371/journal.pone.0057528

Ejemplares similares